BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32646396)

  • 1. Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis.
    Lin JL; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Huang CM
    BMC Cancer; 2020 Jul; 20(1):638. PubMed ID: 32646396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis.
    Li P; Wu H; Zhang H; Shi Y; Xu J; Ye Y; Xia D; Yang J; Cai J; Wu Y
    Gut; 2015 Sep; 64(9):1419-25. PubMed ID: 25239119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.
    Spence AD; Busby J; Johnston BT; Baron JA; Hughes CM; Coleman HG; Cardwell CR
    Gastroenterology; 2018 Mar; 154(4):849-860.e1. PubMed ID: 29122547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of aspirin and nonsteroidal anti-inflammatory drug use after diagnosis on survival of oesophageal cancer patients.
    van Staalduinen J; Frouws M; Reimers M; Bastiaannet E; van Herk-Sukel MP; Lemmens V; de Steur WO; Hartgrink HH; van de Velde CJ; Liefers GJ
    Br J Cancer; 2016 Apr; 114(9):1053-9. PubMed ID: 27115570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of Sox2 expression in digestive tract cancers: A meta-analysis.
    Du XM; Wang LH; Chen XW; Li YX; Li YC; Cao YW
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):305-312. PubMed ID: 27376796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between aspirin use after diagnosis of colorectal cancer and patient survival: a meta-analysis of observational studies.
    Ye XF; Wang J; Shi WT; He J
    Br J Cancer; 2014 Nov; 111(11):2172-9. PubMed ID: 25180765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies.
    Paleari L; Puntoni M; Clavarezza M; DeCensi M; Cuzick J; DeCensi A
    Clin Oncol (R Coll Radiol); 2016 May; 28(5):317-26. PubMed ID: 26712086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of aspirin-guided therapy of colorectal cancer.
    Mädge JC; Stallmach A; Kleebusch L; Schlattmann P
    J Cancer Res Clin Oncol; 2022 Jun; 148(6):1407-1417. PubMed ID: 35171329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer.
    Domingo E; Church DN; Sieber O; Ramamoorthy R; Yanagisawa Y; Johnstone E; Davidson B; Kerr DJ; Tomlinson IP; Midgley R
    J Clin Oncol; 2013 Dec; 31(34):4297-305. PubMed ID: 24062397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of aspirin postdiagnosis improves survival for colon cancer patients.
    Bastiaannet E; Sampieri K; Dekkers OM; de Craen AJ; van Herk-Sukel MP; Lemmens V; van den Broek CB; Coebergh JW; Herings RM; van de Velde CJ; Fodde R; Liefers GJ
    Br J Cancer; 2012 Apr; 106(9):1564-70. PubMed ID: 22454078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies.
    Qiao Y; Yang T; Gan Y; Li W; Wang C; Gong Y; Lu Z
    BMC Cancer; 2018 Mar; 18(1):288. PubMed ID: 29534696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.
    Hamada T; Cao Y; Qian ZR; Masugi Y; Nowak JA; Yang J; Song M; Mima K; Kosumi K; Liu L; Shi Y; da Silva A; Gu M; Li W; Keum N; Zhang X; Wu K; Meyerhardt JA; Giovannucci EL; Giannakis M; Rodig SJ; Freeman GJ; Nevo D; Wang M; Chan AT; Fuchs CS; Nishihara R; Ogino S
    J Clin Oncol; 2017 Jun; 35(16):1836-1844. PubMed ID: 28406723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of EZH2 expression in patients with oesophageal cancer: a meta-analysis.
    Wang Y; Gao F; Zhao M; Li B; Xing D; Wang J; Yang Y
    J Cell Mol Med; 2016 May; 20(5):836-41. PubMed ID: 26859127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of GSTP1 Ile105Val polymorphism in clinical outcomes of chemotherapy in gastric and colorectal cancers: a systematic review and meta-analysis.
    Shen X; Wang J; Yan X; Ren X; Wang F; Chen X; Xu Y
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1285-302. PubMed ID: 27154175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential biomarker for aspirin use in colorectal cancer therapy.
    Langley RE; Rothwell PM
    Nat Rev Clin Oncol; 2013 Jan; 10(1):8-10. PubMed ID: 23207797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal Cancer.
    Davis JS; Chavez JC; Kok M; San Miguel Y; Lee HY; Henderson H; Overman MJ; Morris V; Kee B; Fogelman D; Advani SM; Johnson B; Parseghian C; Shen JP; Dasari A; Shaw KR; Vilar E; Raghav KP; Shureiqi I; Wolff RA; Meric-Bernstam F; Maru D; Menter DG; Kopetz S; Chang S
    JAMA Netw Open; 2022 Oct; 5(10):e2236357. PubMed ID: 36239938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study.
    Lee JM; Park YM; Yun JS; Ahn YB; Lee KM; Kim DB; Lee JM; Han K; Ko SH
    PLoS One; 2020; 15(1):e0226351. PubMed ID: 31978054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study.
    Liu P; McMenamin ÚC; Spence AD; Johnston BT; Coleman HG; Cardwell CR
    BMC Cancer; 2019 Oct; 19(1):1017. PubMed ID: 31664951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.
    González-Pérez A; García Rodríguez LA; López-Ridaura R
    BMC Cancer; 2003 Oct; 3():28. PubMed ID: 14588079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTGS2 (Cyclooxygenase-2) expression and survival among colorectal cancer patients: a systematic review.
    Kunzmann AT; Murray LJ; Cardwell CR; McShane CM; McMenamin UC; Cantwell MM
    Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1490-7. PubMed ID: 23810915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.